hhs_forecastForecast58he0vhw2zn
The Cellularis Discovery by Early Sight
Department of Health and Human Services.Food and Drug Administration.75F401
- Est. solicitation
- May 1, 2026
- Date posted
- —
- Source
- Open forecast
Description
The Cellularis Discovery by Early Sight is one of the first commercial clinical AO retinal cameras. It will be used to advance the development of new cellular imaging biomarkers for the Ophthalmic Devices Program. In particular, many new methods and tools will be developed using this system. It fulfills the FDA mission to foster clinical translation of innovative medical device technology.
Planning details
- Estimated value
- > $25K and < $250K
- Est. solicitation date
- May 1, 2026
- Anticipated award
- Jun 1, 2026
Classifications
- NAICS334516
- PSC334516